SONG PAUL Y. (Chief Executive Officer) purchased 0.1% of their position (152.63 shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $430.00 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/22/2023ACC: 0001209191-23-056523
DirectorOfficer· Chief Executive Officer
Since Sep 2023
+152.63
Net shares
Net buyer
$430.00
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
152.63 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+100.00
Price / share
$2.80
Trade value
$280.00
% of position
0.1%
11/21/2023
170.31K→170.41K
Common Stock
Direct
Shares
+52.63
Price / share
$2.85
Trade value
$150.00
% of position
0.0%
11/22/2023
170.41K→170.46K
Total
Net shares
+152.63
Net value
$430.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2023 | P · Purchase | +100.00 | $2.80 | $280.00 | 0.1% | 170.31K | 170.41K |
| Common Stock Direct | 11/22/2023 | P · Purchase | +52.63 | $2.85 | $150.00 | 0.0% | 170.41K | 170.46K |
| Total | +152.63 | $430.00 | ||||||
Derivative Transactions0
No derivative transactions reported